NIH-funded research R03 grant

Investigating how a gene affects motivation and behavior in Prader-Willi Syndrome

Official title: Role of hypothalamic MAGEL2 in motivation

Funded at Albert Einstein College of Medicine · NIH-10951366 · Data updated 2026-11-12

This study is looking at how a gene called MAGEL2 affects motivation and behavior in people with Prader-Willi Syndrome, using mice to learn more about why they might struggle with weight and metabolism, which could help find better treatments for managing the condition.

More Motivation research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startJuly 8, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$168,000
NIH project number1R03MH137614-01A1
Project IDNIH-10951366 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Prader-Willi Syndrome, particularly those experiencing obesity and related metabolic challenges.

Less likely to help

Patients without Prader-Willi Syndrome or those who do not exhibit symptoms related to motivation and behavior may not benefit from this research.

What this research studies

This research focuses on understanding the role of the MAGEL2 gene in the hypothalamus and its impact on motivation and behavior, particularly in individuals with Prader-Willi Syndrome (PWS). By studying mouse models with a loss of the MAGEL2 gene, researchers aim to uncover the cellular mechanisms that lead to obesity and metabolic issues associated with PWS. The approach involves examining how changes in MAGEL2 expression affect neuropeptide production and body weight regulation. Patients may benefit from insights that could lead to new treatments for managing PWS symptoms.

Why it matters

Potential benefit: If successful, this research could lead to improved management strategies for obesity and behavioral issues in patients with Prader-Willi Syndrome.

How similar studies have gone: Previous research on the MAGEL2 gene in mouse models has shown promising results, indicating that this approach could yield valuable insights into PWS.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Jo, Young-Hwan — Albert Einstein College of Medicine
  • Study coordinator: Jo, Young-Hwan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.